Dambkowski Carl
SEC CIK 1983476 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ORKA | Oruka Therapeutics, Inc. | Dir | 38.7K | — | $8.65M | 4 | 2026-01-23 | 2026-06-11 |
Most active insiders at ORKA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir, 10% | — | $300.01M |
| 2 | Dambkowski Carl | Dir | — | $8.65M |
| 3 | Klein Lawrence Otto | CEO, Dir | — | $7.31M |
| 4 | Quinlan Paul T | GC | — | $6.76M |
| 5 | Goncalves Joana | Chief Medical Off | — | $4.54M |
| 6 | Agarwal Arjun | SVP, Fin | — | $4.33M |
| 7 | Sandler Laura Lee | COO | — | $1.94M |
| 8 | Edwards Larry Todd | Chief Commercial Off | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-06-12 16:36 | 2026-06-11+ | ORKA | Oruka Therapeutics, Inc. | Dambkowski Carl | Dir | S - Sale | $70.13 | -35.0K | 38.7K | -47% | -$2.45M |
| DMT | 2026-05-22 16:54 | 2026-05-21 | ORKA | Oruka Therapeutics, Inc. | Dambkowski Carl | Dir | M - OptEx | $7.95 | +62.3K | 178.7K | +53% | +$494.8K |
| DMT | 2026-05-22 16:54 | 2026-05-21 | ORKA | Oruka Therapeutics, Inc. | Dambkowski Carl | Dir | S - Sale+OE | $58.97 | -105.0K | 73.7K | -59% | -$6.19M |
| 2026-01-23 | 2026-01-23 | ORKA | Oruka Therapeutics, Inc. | Dambkowski Carl | Dir | J - Other | $0.00 | +116.5K | 116.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations